Literature DB >> 22067439

The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.

Soumaya Loued1, Maxim Isabelle, Hicham Berrougui, Abdelouahed Khalil.   

Abstract

AIM: The aims of this study were to investigate whether purified PON1 can reduce the pro-inflammatory effect of oxidized phospholipids and whether the effect depended on its association with HDL. MAIN
METHODS: Lipid peroxidation was induced by copper ions and was measured using the conjugated diene method. Lysophosphatidylcholine (lyso-PC) formation was measured by HPLC with evaporative light scattering detection (ELSD) and ICAM-1 expression on Ea.hy926 endothelial cells was analyzed by flow cytometry. KEY
FINDINGS: Purified PON1 significantly inhibited copper-induced oxidation of LDL and HDL, causing a 60.5% and 77.7% decrease in conjugated diene formation, respectively. Incubating PON1 with oxLDL caused a significant increase in lyso-PC levels, while oxHDL caused a significant decrease. PON1 (12.5 to 50 μg/mL) had a pro-inflammatory effect in the presence of oxLDL, increasing ICAM-1 levels in Ea.hy926 cells by 33.0% and 40.6% (p<0.001) respectively, and had an anti-inflammatory effect in the presence of oxHDL, causing a 3-fold reduction in ICAM-1 levels. PON1 also caused a significant decrease in TNFα and purified lyso-PC-induced ICAM-1 expression. The results obtained with reconstituted HDL as well as LCAT and PAF-AH inhibitors suggested that the anti-inflammatory effect of PON1 against oxidized lipids is dependent on its association with HDL. SIGNIFICANCE: Our results clearly showed that PON1 is involved in the anti-inflammatory effect of HDL and that the effect appears to depend on its association with HDL.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067439     DOI: 10.1016/j.lfs.2011.10.018

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy.

Authors:  S D Pektas; G Akoglu; A Metin; S Neselioglu; O Erel
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

2.  Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?

Authors:  Cemil Ertürk; Mehmet Akif Altay; Ali Bilge; Hakim Çelik
Journal:  Clin Rheumatol       Date:  2017-06-19       Impact factor: 2.980

Review 3.  Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Authors:  Amy S Shah; Lirong Tan; Jason Lu Long; W Sean Davidson
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 4.  PON1 and Mediterranean Diet.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Nutrients       Date:  2015-05-27       Impact factor: 5.717

5.  Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport.

Authors:  Souade Ikhlef; Hicham Berrougui; Olivier Kamtchueng Simo; Echarki Zerif; Abdelouahed Khalil
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

6.  Long term stability of paraoxonase-1 and high-density lipoprotein in human serum.

Authors:  Piet K Beekhof; Maryana Gorshunska; Eugène H J M Jansen
Journal:  Lipids Health Dis       Date:  2012-05-14       Impact factor: 3.876

7.  Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study.

Authors:  Anabel García-Heredia; Judit Marsillach; Anna Rull; Iris Triguero; Isabel Fort; Bharti Mackness; Michael Mackness; Diana M Shih; Jorge Joven; Jordi Camps
Journal:  Mediators Inflamm       Date:  2013-05-22       Impact factor: 4.711

8.  Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.

Authors:  Abdelghani Bounafaa; Hicham Berrougui; Noreddine Ghalim; Boubker Nasser; Abdallah Bagri; Abderrahmane Moujahid; Souad Ikhlef; Pamela Camponova; Najoua Yamoul; Olivier Kamtchueng Simo; Abdelkhalid Essamadi; Abdelouahed Khalil
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

9.  A Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How this Association Was Augmented by Poor Glycaemic Control.

Authors:  Jane McEneny; Jane-Ann Daniels; Anne McGowan; Anjuli Gunness; Kevin Moore; Michael Stevenson; Ian S Young; James Gibney
Journal:  J Diabetes Res       Date:  2015-10-18       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.